Prevention of Noise-induced Damage by Use of Antioxidants

Sponsor
University Hospital, Antwerp (Other)
Overall Status
Unknown status
CT.gov ID
NCT01727492
Collaborator
(none)
30
1
2

Study Details

Study Description

Brief Summary

The current study is a dubble-blinde placebo-controlled cross-over study verifying the preventive effect of antioxidants on noise-induced hearing loss (NIHL) and noise-induced tinnitus (NIT). The antioxidants comprise of a mixture of magnesium and n-acetylcystein which should be taken 1h before leisure noise above 100dB for at least 30 minutes.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Study Start Date :
Nov 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: sugar pill

Active Comparator: Antioxidantia

Dosage: 600mg n-acetylcystein and 200mg magnesium intake: 1 hour before leisure noise exposure above 100dB of at least 30 minutes frequency: 4 separate events (2x placebo, 2x antioxidants)

Drug: Antioxidantia

Outcome Measures

Primary Outcome Measures

  1. Protection against noise-induced tinnitus due to antioxidants []

    Antioxidants protect against temporary threshold shift. The most prevalent cause of noise-induced tinnitus is noise-induced hearing loss. Therefore, it is assumed that the preventive intake of antioxidants prior to a loud event, might protect against threshold shift as well as noise-induced tinnitus. A 50% decrease of tinnitus loudness scored on a Visual Analogue Scale (VAS) compared to placebo trials is expected.

Secondary Outcome Measures

  1. Change of tinnitus duration []

    It is expected that with the intake of antioxidants noise-induced tinnitus is prevented or reduced after loud music exposure. In addition, it is expected that the tinnitus persistence is shortened compared to the placebo arm.

Other Outcome Measures

  1. Decrease of temporary threshold shift in antioxidant trials compared to placebo trials []

    A limited number of participants will have audiological testing (audiometry including high frequency audiometry, speech-in-noise testing and otoacoustic emissions) prior to the musical event as well as the morning after noise exposure in order to measure the effects of antioxidants on the hearing thresholds and hearing performance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age: 18-25 years old

  • Temporary tinnitus after noise exposure: loudness >5 on a VAS

Exclusion Criteria:
  • middle ear problems

  • Allergy for magnesium or n-acetylcystein

  • Use of hearing protection when going out

Contacts and Locations

Locations

Site City State Country Postal Code
1 Antwerp University Hospital Antwerp Edegem Belgium 2650

Sponsors and Collaborators

  • University Hospital, Antwerp

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ethisch Comité UZ Antwerpen, Ethics Comittee UZ Antwerpen, University Hospital, Antwerp
ClinicalTrials.gov Identifier:
NCT01727492
Other Study ID Numbers:
  • 12/18/172
First Posted:
Nov 16, 2012
Last Update Posted:
Nov 6, 2013
Last Verified:
Nov 1, 2013
Keywords provided by Ethisch Comité UZ Antwerpen, Ethics Comittee UZ Antwerpen, University Hospital, Antwerp
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 6, 2013